Literature DB >> 19669556

Complexation of biologically active aromatic compounds with DNA in the presence of theophylline.

A A Hernandez Santiago1, D D Andrejuk, A M Cervantes Tavera, D B Davies, M P Evstigneev.   

Abstract

(1)H NMR measurements (500 MHz) have been used to determine the equilibrium hetero-association constants of theophylline (THP) with various biologically active aromatic compounds (daunomycin, novantrone, ethidium bromide, proflavine, norfloxacin) and the complexation constants of THP with both single- and double-stranded oligonucleotides in solution. The results provide a quantitative estimation of the effect of THP on the binding of aromatic ligands with DNA, and a determination of the fraction of aromatic ligand removed from DNA on addition of THP.

Entities:  

Year:  2009        PMID: 19669556      PMCID: PMC2669117          DOI: 10.1007/s10867-008-9124-x

Source DB:  PubMed          Journal:  J Biol Phys        ISSN: 0092-0606            Impact factor:   1.365


  22 in total

1.  RNA binding efficacy of theophylline, theobromine and caffeine.

Authors:  I Maria Johnson; S G Bhuvan Kumar; R Malathi
Journal:  J Biomol Struct Dyn       Date:  2003-04

2.  Spectroscopic and molecular modeling studies of caffeine complexes with DNA intercalators.

Authors:  R W Larsen; R Jasuja; R K Hetzler; P T Muraoka; V G Andrada; D M Jameson
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

3.  Caffeine and other xanthines as cytochemical blockers and removers of heterocyclic DNA intercalators from chromatin.

Authors:  Mark B Lyles; Ivan L Cameron
Journal:  Cell Biol Int       Date:  2002       Impact factor: 3.612

4.  NMR evidence for self-association of theophylline in aqueous solution.

Authors:  A L Thakkar; L G Tensmeyer; W L Wilham
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

5.  Hetero-association of caffeine and aromatic drugs and their competitive binding with a DNA oligomer.

Authors:  D B Davies; D A Veselkov; L N Djimant; A N Veselkov
Journal:  Eur Biophys J       Date:  2001-09       Impact factor: 1.733

6.  Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198.

Authors:  F Traganos; J Kapuscinski; Z Darzynkiewicz
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

7.  The modulation by xanthines of the DNA-damaging effect of polycyclic aromatic agents. Part II. The stacking complexes of caffeine with doxorubicin and mitoxantrone.

Authors:  Jacek Piosik; Malgorzata Zdunek; Jan Kapuscinski
Journal:  Biochem Pharmacol       Date:  2002-02-15       Impact factor: 5.858

8.  Formation of stacking complexes between caffeine (1,2,3-trimethylxanthine) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine may attenuate biological effects of this neurotoxin.

Authors:  Katarzyna Ulanowska; Jacek Piosik; Anna Gwizdek-Wiśniewska; Grzegorz We Grzyn
Journal:  Bioorg Chem       Date:  2005-10       Impact factor: 5.275

Review 9.  Evaluation of the genotoxicity data on caffeine.

Authors:  S M D'Ambrosio
Journal:  Regul Toxicol Pharmacol       Date:  1994-06       Impact factor: 3.271

10.  Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines.

Authors:  A Lelo; J O Miners; R Robson; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1986-01       Impact factor: 6.875

View more
  4 in total

1.  Biological physics in México: Review and new challenges.

Authors:  Enrique Hernández-Lemus
Journal:  J Biol Phys       Date:  2011-02-11       Impact factor: 1.365

2.  On the reliability of quantitation of biological effect in drug-interceptor-DNA systems.

Authors:  Anatoly S Buchelnikov; Vladyslav P Evstigneev; Leticia E Rodríguez Oropeza; Maxim P Evstigneev
Journal:  Eur Biophys J       Date:  2013-02-11       Impact factor: 1.733

3.  Quantification of the interceptor action of caffeine on the in vitro biological effect of the anti-tumour agent topotecan.

Authors:  M P Evstigneev; A A Mosunov; V P Evstigneev; H G Parkes; D B Davies
Journal:  Eur Biophys J       Date:  2011-06-15       Impact factor: 1.733

4.  General analysis of competitive binding in drug-interceptor-DNA systems.

Authors:  A S Buchelnikov; A A Hernandez Santiago; M Gonzalez Flores; R Vazquez Ramirez; D B Davies; M P Evstigneev
Journal:  Eur Biophys J       Date:  2012-01-03       Impact factor: 1.733

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.